Tuo Wei
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Molecular Biology top 1%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- CRISPR and Genetic Engineering
Papers in
-
- RNA Interference and Gene Delivery 31
- Advanced biosensing and bioanalysis techniques 19
- CRISPR and Genetic Engineering 10
- Biomaterials 17
- Nanoparticle-Based Drug Delivery 15
- Co-authors
- Qiang Cheng (29 shared papers)Daniel J. Siegwart (13 shared papers)Lukas Farbiak (8 shared papers)Lindsay T. Johnson (6 shared papers)Sean A. Dilliard (1 shared paper)Xing‐Jie Liang (19 shared papers)Juan Liu (12 shared papers)Huili Ma (5 shared papers)
- Journals
- Biomaterials (7 papers)Advanced Materials (5 papers)Nature Communications (4 papers)Nano Letters (3 papers)ACS Nano (3 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Tuo Wei
51 papers receiving 7.4k citations
Tuo Wei's Hit Papers
Peers
Comparison fields: 5 of 135
- Biomaterials 1.8k
- Molecular Biology 4.8k
- Biomedical Engineering 1.8k
- Pharmaceutical Science 216
- Immunology 697
Countries citing papers authored by Tuo Wei
This map shows the geographic impact of Tuo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuo Wei more than expected).
Fields of papers citing papers by Tuo Wei
This network shows the impact of papers produced by Tuo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuo Wei. The network helps show where Tuo Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Tuo Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing Hit paper breakdown → | 2020 | 1689 |
| 2 | Size-Dependent Localization and Penetration of Ultrasmall Gold Nanoparticles in Cancer Cells, Multicellular Spheroids, and Tumors in Vivo Hit paper breakdown → | 2012 | 749 |
| 3 | Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing Hit paper breakdown → | 2021 | 518 |
| 4 | Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing Hit paper breakdown → | 2020 | 462 |
| 5 | Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery Hit paper breakdown → | 2022 | 374 |
| 6 | 2015 | 305 | |
| 7 | Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy Hit paper breakdown → | 2023 | 303 |
| 8 | 2012 | 289 | |
| 9 | 2011 | 253 | |
| 10 | Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy Hit paper breakdown → | 2022 | 195 |
| 11 | 2016 | 186 | |
| 12 | 2018 | 185 | |
| 13 | 2017 | 183 | |
| 14 | 2013 | 167 | |
| 15 | Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models Hit paper breakdown → | 2023 | 127 |
| 16 | 2020 | 103 | |
| 17 | 2010 | 95 | |
| 18 | 2021 | 89 | |
| 19 | 2016 | 80 | |
| 20 | 2021 | 77 |
About Tuo Wei
Tuo Wei is a scholar working on Molecular Biology, Biomaterials, Genetics, Biomedical Engineering and Polymers and Plastics, having authored 56 papers that have together received 7.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (31 papers), Advanced biosensing and bioanalysis techniques (19 papers), Nanoparticle-Based Drug Delivery (15 papers), Virus-based gene therapy research (11 papers), CRISPR and Genetic Engineering (10 papers), Nanoplatforms for cancer theranostics (5 papers), Dendrimers and Hyperbranched Polymers (4 papers) and Gold and Silver Nanoparticles Synthesis and Applications (3 papers). The work is most often cited by research in Biomaterials (1.8k citations), Molecular Biology (4.8k citations), Biomedical Engineering (1.8k citations), Pharmaceutical Science (216 citations) and Immunology (697 citations). Tuo Wei has collaborated with scholars based in China, United States and India. Frequent co-authors include Qiang Cheng, Daniel J. Siegwart, Lukas Farbiak, Lindsay T. Johnson, Sean A. Dilliard, Xing‐Jie Liang, Juan Liu, Huili Ma, Shuaidong Huo and Xueliang Yu. Their work appears in journals such as Biomaterials, Advanced Materials, Nature Communications, Nano Letters and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.